Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits

被引:7
作者
Apostel, F
Dammann, R
Pfeifer, GP
Greeve, J
机构
[1] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Innere Med, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Inst Human Genet & Med Biol, Halle Saale, Germany
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Biol, Duarte, CA 91010 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2002年 / 1577卷 / 03期
关键词
apolipoprotein; 13; mRNA editing; promoter; CpG dinucleotide methylation; transgenic rabbit;
D O I
10.1016/S0167-4781(02)00412-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Editing of apolipoprotein (apo) B mRNA in liver limits the plasma LDL levels in horses, dogs, rats or mice. Species such as man or rabbit do not edit the hepatic apo B mRNA and are therefore susceptible to atherosclerosis and coronary artery disease due to elevated plasma LDL levels. The catalytic subunit APOBEC-1 is the only missing component of the apo B mRNA editing enzyme complex in the human or rabbit liver. Here we describe the generation of transgenic rabbits in which APOBEC-1 expression is mediated by the proximal promoter of the rat APOBEC-1 gene. These transgenic rabbits are healthy and fertile, and rat APOBEC-1 mRNA is expressed in liver, intestine, kidney, lung, brain and muscle. The transgenic APOBEC-1 expression is low and not sufficient to induce editing in rabbit liver. In rat, the proximal APOBEC-1 promoter demonstrates a progressive loss of CpG dinucleotide methylation towards the core promoter region that is entirely unmethylated. In the transgenic rabbits, this distinct pattern of CpG methylation is lost, and throughout the entire rat APOBEC-1 promoter, > 90% of the CpGs are methylated. Thus, the weak proximal rat APOBEC-1 promoter appears to be down-regulated in the rabbit and may be species-specific. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:384 / 394
页数:11
相关论文
共 32 条
[1]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[2]   CPG methylation as a mechanism for the regulation of E2F activity [J].
Campanero, MR ;
Armstrong, MI ;
Flemington, EK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6481-6486
[3]   APOLIPOPROTEIN B-48 IS THE PRODUCT OF A MESSENGER-RNA WITH AN ORGAN-SPECIFIC IN-FRAME STOP CODON [J].
CHEN, SH ;
HABIB, G ;
YANG, CY ;
GU, ZW ;
LEE, BR ;
WENG, SA ;
SILBERMAN, SR ;
CAI, SJ ;
DESLYPERE, JP ;
ROSSENEU, M ;
GOTTO, AM ;
LI, WH ;
CHAN, L .
SCIENCE, 1987, 238 (4825) :363-366
[4]   Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319
[5]  
DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482
[6]   Distinct promoters induce APOBEC-1 expression in rat liver and intestine [J].
Greeve, J ;
Axelos, D ;
Welker, S ;
Schipper, M ;
Greten, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (07) :1079-1092
[7]   Absence of APOBEC-1 mediated mRNA editing in human carcinomas [J].
Greeve, J ;
Lellek, H ;
Apostel, F ;
Hundoegger, K ;
Barialai, A ;
Kirsten, R ;
Welker, S ;
Greten, H .
ONCOGENE, 1999, 18 (46) :6357-6366
[8]  
Greeve J, 1996, J LIPID RES, V37, P2001
[9]  
GREEVE J, 1993, J LIPID RES, V34, P1367
[10]   MOLECULAR AND METABOLIC BASIS FOR THE METABOLIC DISORDER NORMOTRIGLYCERIDEMIC ABETALIPOPROTEINEMIA [J].
HARDMAN, DA ;
PULLINGER, CR ;
HAMILTON, RL ;
KANE, JP ;
MALLOY, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1722-1729